THIS WARRANT AND THE SHARES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGIS-TERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. EXCEPT AS OTHERWISE SET FORTH HEREIN OR IN A SECURITIES PURCHASE AGREEMENT DATED AS OF JUNE 14, 2005,...Warrant Agreement • September 6th, 2005 • Grant Life Sciences, Inc. • In vitro & in vivo diagnostic substances • New York
THIS CERTIFIES THAT, for value received, [________] or its registered assigns, is entitled to purchase from Grant Life Sciences, Inc. a Nevada corporation (the “Company”), at any time or from time to time during the period specified in Paragraph 2 hereof, [________] fully paid and nonassessable shares of the Company’s Common Stock, par value $.001 per share (the “Common Stock”), at an exercise price per share equal to $.45 (the “Exercise Price”). The term “Warrant Shares,” as used herein, refers to the shares of Common Stock purchasable hereunder. The Warrant Shares and the Exercise Price are subject to adjustment as provided in Paragraph 4 hereof. The term “Warrants” means this Warrant and the other warrants issued pursuant to that certain Securities Purchase Agreement, dated June 14, 2005, by and among the Company and the Buyers listed on the execution page thereof (the “Securities Purchase Agreement”), including any additional warrants issuable pursuant to Section 4(l) thereof.
